Survey Finds European Public Increasingly Willing to Share Health Data for Personalized Care

A new global survey conducted by Johnson & Johnson MedTech reveals strong public and professional support across Europe for the use of data and technology to drive more personalized and effective healthcare delivery.

The survey, which included respondents from France, Germany, Italy, and the UK, found that 73% of European adults are willing to share their health data in exchange for personalized treatment plans — a figure that exceeds the U.S. general population (67%).

Respondents also expressed strong optimism about the use of technology in clinical education and surgical advancement:

• 76% said they would feel excited about the future of healthcare if technology helped make medical and surgical training easier.

• 65% of the general population expressed excitement about the use of AI in healthcare, rising to 86% among HCPs.

“This growing confidence is encouraging for Europe, as it aligns with the ambition to accelerate the digital transformation of healthcare,” said Dr. Ivo Broeders*, Consultant Surgeon, Professor of Robotics Twente University and Head of the Meander Centre for Artificial Intelligence. “In my experience, a digital ecosystem enhances the surgical experience for both patients and providers. It can result in personalized surgical plans based on individual patient data, real-time insights, better coordination among surgical teams and improved quality of care.”

Survey data also show:

• 89% of European HCPs believe data and technology will significantly support personalized treatment plans.

• 92% agree that technology enhances precision in surgical procedures.

• 90% say it will improve workflow and decision-making across healthcare systems.

The findings point to a shared confidence in the potential of AI, digital platforms, and connected tools to improve care delivery across disciplines. There was also strong support for expanding the use of digital tools in education and workforce development:

• 79% of the general public and 87% of HCPs support using technology to train the next generation of clinicians.

“With our longstanding commitment to support patients and providers across Europe, we champion the transformative potential of data and technology in healthcare,” said Dr. Julia Fishman, Head of Digital Solutions EMEA, Johnson & Johnson MedTech. “As patients and healthcare professionals express a clear appetite for data-driven care, we have a collective responsibility – across industry, policymakers and healthcare systems – to unlock the potential of technology safely and meaningfully.”

As part of this transformation, Johnson & Johnson MedTech is actively deploying new technologies across its cardiovascular, orthopaedic, surgery and vision portfolios. These include:

• AI-powered platforms that analyze patient data before surgery

• Advanced cardiac mapping systems delivering real-time procedural insights

• Surgical solutions that tailor procedures like total knee arthroplasty to each patient’s anatomy

The company also emphasized the importance of greater system-wide data connectivity to fully realize the potential of these technologies at scale.

Survey Methodology
Morning Consult conducted the online survey on behalf of Johnson & Johnson MedTech from August 8 to September 9, 2024, polling 11,412 adults and 964 healthcare professionals (including general surgeons, vision specialists, orthopaedic specialists, and cardiologists) in Brazil, Chile, Colombia, France, Germany, Italy, Japan, Mexico, South Korea, the UK, and the US. Results for the general population have a margin of error of +/-3%; for HCPs, between +/-8–10%. The European sample includes France, Germany, Italy, and the UK.